Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib

Aline Houessinon; Albane Gicquel; Flora Bochereau; Christophe Louandre; Remy Nyga; Corinne Godin; James Degonville; Emma Fournier; Zuzana Saidak; Claire Drullion; Jean-Claude Barbare; Bruno Chauffert; Catherine Francois; Olivier Pluquet; Antoine Galmiche

doi:10.1016/j.canlet.2015.10.032

Article dans une revue

Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib

Aline Houessinon ¹ Albane Gicquel ^{2, 3} Flora Bochereau ¹ Christophe Louandre ^{4, 5} Remy Nyga ⁶ Corinne Godin ^{4, 5} James Degonville Emma Fournier Zuzana Saidak ^{4, 5} Claire Drullion ⁷ Jean-Claude Barbare ⁸ Bruno Chauffert ^{8, 4} Catherine Francois ⁹ Olivier Pluquet ⁷ Antoine Galmiche ^{4, 5}

1 UPJV - Université de Picardie Jules Verne

2 GRAM 2.0 - Groupe de Recherche sur l'Adaptation Microbienne

3 Laboratoire de virologie [Rouen]

4 CHIMERE - CHirurgie, IMagerie et REgénération tissulaire de l’extrémité céphalique - Caractérisation morphologique et fonctionnelle - UR UPJV 7516

5 Laboratoire de Biochimie

6 Service de Parasitologie-Mycologie [CHRU LIlle]

Institut de Microbiologie [CHRU Lille]

7 IBLI - Institut de biologie de Lille - IBL

8 CHU Amiens-Picardie

9 UVCF - Unité de Virologie clinique et fondamentale

Abstract : Sorafenib is the treatment of reference for advanced hepatocellular carcinoma (HCC). A decrease in the serum levels of Alpha-fetoprotein (AFP) is reported to be the biological parameter that is best associated with disease control by sorafenib. In order to provide a biological rationale for the variations of APP, we analyzed the various steps of AFP production in human HCC cell lines exposed to sorafenib. Sorafenib dramatically reduced the levels of APP produced by HCC cells independently of its effect on cell viability. The mRNA levels of APP decreased upon sorafenib treatment, while the AFP protein remained localized in the Golgi apparatus. Sorafenib activated the Regulated Inositol-Requiring Enzyme-1 alpha (IRE-1 alpha) and the PKR-like ER Kinase (PERK)-dependent arms of the Unfolded Protein Response (UPR). The inhibition of IRE-1 alpha partially restored the mRNA levels of AFP upon treatment with sorafenib. The inhibition of both pathways partially prevented the drop in the production of AFP induced by sorafenib. The findings provide new insights on the regulation of APP, and identify it as a biomarker suitable for the exploration of HCC cell proteostasis in the context of therapeutic targeting. (C) 2015 Elsevier Ireland Ltd. All rights reserved.

Type de document :

Article dans une revue

Domaine :

Sciences du Vivant [q-bio]

Liste complète des métadonnées

https://hal-u-picardie.archives-ouvertes.fr/hal-03592366
Contributeur : Louise Dessaivre Connectez-vous pour contacter le contributeur
Soumis le : mardi 1 mars 2022 - 11:37:13
Dernière modification le : mardi 17 mai 2022 - 10:26:13

Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib

Identifiants

Collections

Citation

Exporter

Métriques

10

Alpha-fetoprotein is a biomarker of unfolded protein response and altered proteostasis in hepatocellular carcinoma cells exposed to sorafenib

Identifiants

Collections

Citation

Exporter

Partager

Métriques

10